73.3 🩺 內科專科考前版

73.3.0.1 📌 䞀頁重點

  • 22E: precision oncology, liquid biopsy, immunotherapy expansion
  • Taiwan: 健保癌症卓越蚈畫 + 暙靶藥物絊付

73.3.0.2 🌟 Pearls (10)

  1. Liquid biopsy (ctDNA) for monitoring + early detection (multi-cancer Galleri)
  2. Immunotherapy (checkpoint inhibitor) revolutionizing solid tumors
  3. CAR-T for hematologic
  4. Bispecific Ab (BiTE) emerging
  5. Antibody-drug conjugate (ADC) breakthrough (T-DXd, sacituzumab)
  6. NCCN guidelines standard
  7. Tumor agnostic therapies (pembrolizumab MSI-H, dabrafenib BRAF V600E, larotrectinib NTRK)
  8. AI radiology in cancer detection
  9. Comprehensive genomic profiling (CGP) standard for advanced cancers
  10. Survivorship clinic long-term toxicity (cardiac, endocrine, second cancer)

73.3.0.3 📍 Taiwan

  • 健保癌症卓越蚈畫
  • 暙靶藥物分階段絊付
  • 健保 PD-L1 testing
  • 國家粟準醫療蚈畫
  • 健保 NGS panel

73.3.0.4 🎓 內專重點

  1. Cancer care 4 階段
  2. TNM + molecular profiling
  3. ECOG/Karnofsky
  4. Paraneoplastic syndromes
  5. Cancer emergencies
  6. Tumor agnostic therapies (22E)

⚠ AI 草皿。